Dr. Rocha Lima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Wake Forest Baptist Medical Center
Division of Hematology and Oncology
Winston Salem, NC 27157Phone+1 336-713-5440Fax+1 336-713-5445- Is this information wrong?
Education & Training
- Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 1995 - 1997
- Federal University of Bahia Faculty of MedicineClass of 1989
Certifications & Licensure
- FL State Medical License 2002 - 2026
- SC State Medical License 2015 - 2025
- NC State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 55 citationsA Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcin...Philip A. Philip, Marc Buyse, Angela T. Alistar, Caio M.S.R. Lima, Sanjeev Luther, Timothy S. Pardee, Eric Van Cutsem> ;Future Oncology. 2019 Sep 12
- 8 citationsMolecularly targeted therapies for advanced or metastatic non-small-cell lung carcinomaSoley Bayraktar, Caio Rocha-Lima> ;World Journal of Clinical Oncology. 2013 May 10
- 9 citationsThe nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma.Sofia Palacio, Peter J. Hosein, Isildinha M. Reis, Ikechukwu Immanuel Akunyili, Vinicius Ernani, Terri Pollack, Jessica MacIntyre, Maria H. Restrepo, Jaime R. Merchan,...> ;Journal of Gastrointestinal Oncology. 2018 Feb 1
- Join now to see all
Lectures
- A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of p...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
- A phase I clinical trial of fluorouracil (5-FU) + devimistat (CPI-613) combination in previously treated patients (pts) with metastatic colorectal cancer (MCR).2019 ASCO Annual Meeting - 6/1/2019
Professional Memberships
- Member
Hospital Affiliations
- Atrium Wake Forest BaptistWinston Salem, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: